Save
Regulation of plasminogen activation on cell surfaces and fibrin
ISTH Academy, Tetsumei Urano, 227417
Thromboembolic risk after lumbar spine surgery: a cohort study on 325 000 French patients
ISTH Academy, Joel Coste, 227418
In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents
ISTH Academy, Friedrich Scheiflinger, 227419
McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
ISTH Academy, Kimberly Legault, 227420
Clinical and economic impact of compression in the acute phase of deep vein thrombosis
ISTH Academy, Elham E. Amin, 227423
Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism
ISTH Academy, John-Bjarne Hansen, 227424
Hemorrhagic disorders of fibrinolysis: a clinical review
ISTH Academy, Joline L Saes, 227425
Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability
ISTH Academy, Sylvie Bouvier, 227426
The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban
ISTH Academy, Cristina Duboscq, 227427
The perils of inhibiting deficient factors
ISTH Academy, Zara Sayar, 227428
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 227429
Molecular actions of heparin and their implications in preventing pre‐eclampsia
ISTH Academy, John C. Kingdom, 227430
TC21/RRas2 regulates glycoprotein VI–FcRγ‐mediated platelet activation and thrombus stability
ISTH Academy, Lawrence Goldfinger, 227431
Summertime
ISTH Academy, Session Speakers, 227432
Dual endothelin‐1 receptor antagonism attenuates platelet‐mediated derangements of blood coagulation in Eisenmenger syndrome
ISTH Academy, Fionnuala Ni Ainle, 227433
Move along, nothing to see here: Btk inhibitors stop platelets sticking to plaques
ISTH Academy, Alexander Paul Bye, 227434
Management of postpartum hemorrhage: how to improve maternal outcomes?
ISTH Academy, Johanna van der Bom, 227435
Pleiotropic effects of the hemostatic system
ISTH Academy, Henri Spronk, 227436
Issue Information
ISTH Academy, Session Speakers, 227438
Reduction in physical function in women after venous thromboembolism
ISTH Academy, Kaitlin A Hagan, 227439
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study
ISTH Academy, Imre Bodó, 227440
Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity
ISTH Academy, John Morser, 227441
What the neighbors say
ISTH Academy, Session Speakers, 227442
Immune Thrombocytopenia: Pathophysiology and Treatment: Future Directions
ISTH Academy, Philip Choi, 223617
The Measurement of Mean Platelet Volume in the Differential Diagnosis of ITP: Case Report and State of the Art (Case Based Presentation)
ISTH Academy, Patrizia Noris, 223616
Low Dose DOACs for the Secondary Prevention of VTE (Case Based Presentation)
ISTH Academy, Jeffrey I. Weitz, 223621
Abnormal Bleeding in Mild/Moderate ITP: Case Report and the Role of Platelet Dysfunction (Case Based Presentation)
ISTH Academy, Andrew Frelinger, 223615
DOACs for the Treatment of VTE in Unusual Site VTE (Case Based Presentation)
ISTH Academy, Walter Ageno, 223620
Immune Platelet Disorders (Case Based Presentation)
ISTH Academy, Donald Arnold, 223614
DOACs for the Treatment of Cancer Associated Thrombosis (Case Based Presentation)
ISTH Academy, Marc Carrier, 223619
The Role of Platelets in Vascular Integrity and in the Prevention of Bleeding
ISTH Academy, Michael Berndt, 223613
Unmet Clinical Needs in the Management of Venous Thromboembolism
ISTH Academy, Sabine Eichinger, 223618
Sepsis Reconsidered
ISTH Academy, Clifford S. Deutschman, 223608
Targeting the Contact System for Treatment of Thrombo-Inflammatory Diseases
ISTH Academy, Thomas Renné, 223612
DIC in Sepsis and Obstetrics
ISTH Academy, Beverly Hunt, 223607
Medical Device Thrombosis- Causes and Prevention (Case Based Presentation)
ISTH Academy, Jeffrey I. Weitz, 223611
Sepsis: A Critical Care Physician Perspective
ISTH Academy, Jerry J. Zimmerman, 223606
Hereditary Angioedema - Examining a Complex Etiology (Case Based Presentation)
ISTH Academy, Marcel Levi, 223610
A Hemostasis Perspective on How to Mitigate Sepsis Mortality
ISTH Academy, Toshiaki Iba, 223605
Sepsis a Disorder of Coagulation or Platelets?
ISTH Academy, Dermot Cox, 223604
Resurrection of the Contact System - What We Now Know and What Remains to Be Determined
ISTH Academy, Coen Maas, 223609
Expert Commentary
ISTH Academy, Peter Lenting, 223706
Expert Commentary
ISTH Academy, Steven Pipe, 223707
Closing
ISTH Academy, Guy Young, 223708
Recommendations of the International Council for Standardization in Hematology (ICSH) for Laboratory Measurement of Direct Oral Anticoagulants (DOAC)
ISTH Academy, Robert Gosselin, 223727
The DaXa Inhibition Test: A Concept for a Universal and Easily Available aXa Test That Measures the Direct Inhibitory Effect of All Anti-Xa Drugs
ISTH Academy, Joost van Pelt, 223728
Reversal and Biological Strategies in French GIHP-NACO Registry: Need for Guidance
ISTH Academy, Pierre Albaladejo, 223729
Novel Approaches for Immune Tolerance Induction
ISTH Academy, David Lillicrap, 223698
Extended Half-Life Products and ITI
ISTH Academy, Manuel Carcao, 223699
Prophylaxis with ITI
ISTH Academy, Carmen Escuriola-Ettingshausen, 223700
Debate: ITI in the Era of Emicizumab - Yes
ISTH Academy, Ri Liesner, 223701
Debate: ITI in the Era of Emicizumab - No
ISTH Academy, Beatrice Nolan, 223702
Welcome and Introduction
ISTH Academy, Mark Crowther, 223723
DOACs Measurements and Clinical Events: Recent Evidences from the Literature and the Presentation of the MAS - Measure and See" Study"
ISTH Academy, Sophie Testa, 223724
Calibration of SSC/ISTH Plasma Standard Lot #5
ISTH Academy, Craig Thelwell, 223691
Calibration of WHO International Standard for Factor V
ISTH Academy, Anthony Hubbard, 223692
Hemophilia Carriers Nomenclature
ISTH Academy, Robert F. Sidonio Jr., 223693
Gene Therapy Clinical Trials
ISTH Academy, Alok Srivastava, 223694
EHC Partners Programme
ISTH Academy, Brian O'Mahony, 223695
Plasminogen Deficiency
ISTH Academy, Charles Nakar, 223696
Diagnosing Rare Platelet Disorders
ISTH Academy, Diane Nugent, 223697
Impact of DOACs on LAC Testing: The Australian Perspective
ISTH Academy, Jennifer Curnow, 223714
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOAC on Several Tests for Thrombophilia Screening
ISTH Academy, Francois Mullier, 223715
Unusual Site Thrombosis Treated with DOACs
ISTH Academy, Nicoletta Riva, 223717
CVT Registry
ISTH Academy, Francesco Dentali, 223718
START Events registry
ISTH Academy, Sophie Testa, 223719
ORTHO-START registry
ISTH Academy, Elvira Grandone, 223720
DOAC Testing in Ontario: Results from IQMH
ISTH Academy, Karen Moffat, 223721
Venous Stent Registry
ISTH Academy, Sam Schulman, 223722
Introduction to SSC Sessions
ISTH Academy, Guy Young, 223684
Top Abstract Presentation: Enhanced FIX Collagen IV Binding Shows Improved Hemostatic Effects in a Hemophilia B Mouse Model
ISTH Academy, Davide Matino, 223685
Treatment of Breakthrough Bleeds
ISTH Academy, Peter Collins, 223686
Laboratory Issues
ISTH Academy, Stefan Tiefenbacher, 223688
Surveillance and Monitoring for Adverse Events
ISTH Academy, Flora Peyvandi, 223689
Institute for Clinical and Economic Review of Emicizumab
ISTH Academy, David Rind, 223690
Welcome and Introduction
ISTH Academy, Mark Crowther, 223709
Top Abstract Presentation: Outcomes in Non-Valvular Atrial Fibrillation Patients with Good and Poor INR Control After Switching to Direct Oral Anticoagulants
ISTH Academy, Scott Kaatz, 223710
Is Laboratory Monitoring of DOAC Required in Patients with APS- Insight from the Canadian RAPS Study
ISTH Academy, Kim Legault, 223713
Novel Approaches to Pharmacokinetics and Individualized Pharmacologic Dosing of Factor Products
ISTH Academy, Peter Collins, 223597
Why It Is Safe to Continue Antithrombotics for Some Procedures and Not Others?
ISTH Academy, Peter Verhamme, 223603
Using Electronic Data to Manage Hemophilia
ISTH Academy, Niamh O'Connell, 223596
Perioperative Prevention of Thromboembolism: An Asian Perspective
ISTH Academy, Heng Joo Ng, 223602
Hemophilia A With Inhibitors (Case Based Presentation)
ISTH Academy, Carmen Escuriola-Ettingshausen, 223595
Determinants of Bleeding in a Perioperative Setting (Case Based Presentation)
ISTH Academy, Charles Marc Samama, 223601
Hemophilia B (Case Based Presentation)
ISTH Academy, Johnny Mahlangu, 223594
Determinants of Acute Coronary Syndromes in a Perioperative Setting
ISTH Academy, Ursula Rauch-Kröhnert, 223600
Hemophilia A (Case Based Presentation)
ISTH Academy, Beatrice Nolan, 223593
The Role for Laboratory Testing Before Urgent Surgery (Case Based Presentation)
ISTH Academy, Adam Cuker, 223599
The History of Hemophilia Replacement Therapy: From Samuel Lane to Extended Half-Life Factor Replacement Therapy
ISTH Academy, Kathelijn Fischer, 223592
Perioperative Mechanisms of Thrombosis
ISTH Academy, John-Bjarne Hansen, 223598
Direct Oral Anticoagulant Use in Obese Patients: Preliminary Results of a Pilot Study
ISTH Academy, Laura Talamo, 213461
Change of Rivaroxaban Anticoagulant Effect during the 24 Hours
ISTH Academy, Olesia Matvienko, 213684
D-dimer Levels for Prediction of Symptomatic Central Venous Catheter-related Thrombosis in Breast Cancer Patients
ISTH Academy, Ilham Benzidia, 213756
Risk of Recurrent Venous Thromboembolism in Pregnancy and Postpartum Period: Results from the MEGA Follow-up Study
ISTH Academy, Luuk J.J. Scheres, 213787
Variable Response in Individuals to Rivaroxaban and Apixaban over Time
ISTH Academy, Suzanne zwaveling, 213879
Stability of Thrombin Generation and Thrombin Dynamics in Healthy Individuals over a One-year Period
ISTH Academy, Joke Konings, 213911
Knowledge Derived from a Hospitalar Thromboprophylaxis Program
ISTH Academy, maria chindamo, 213942
Clinical Characteristics and Outcome of Patients with Subsegmental Pulmonary Embolism
ISTH Academy, Farès Moustafa, 213970
The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism
ISTH Academy, Éva Katona, 214021
Anticoagulation Monitoring of Pediatric Patients on Life Support Sytems Using a Microfluidic Device that Mimics Complex Vascular Architecture
ISTH Academy, David Luna, 214045

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings